The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function
- PMID: 8630400
The natural killer-related receptor for HLA-C expressed on T cells from CD3+ lymphoproliferative disease of granular lymphocytes displays either inhibitory or stimulatory function
Abstract
Four patients with lymphoproliferative disease of granular lymphocytes (LDGL) coexpressing CD3 and the natural killer (NK)-related "p58" receptor for HLA-C alleles were studied. These CD3+p58+ LDGLs have been detected among a series of 44 CD3+ LDGLs analyzed. Two patients with LDGL (GI and BA) expressed only the p58 molecule defined by the GL-183 and CH-L monoclonal antibodies (MoAbs), while the cases of patients PU and MA also coexpressed the molecular form identified by EB6 anti-p58 MoAb. Three LDGL cases (GI, MA, and PU) displayed the CD8+4-CD16+ T-cell receptor (TCR)alpha/beta+ phenotype, while one patient (BA) was CD8+4+CD16+ TCRalpha/beta+. Freshly isolated granular lymphocytes (GL) from these cases displayed cytolytic activity in an anti-CD3 MoAb-triggered redirected killing assay against the Fcgamma-receptor+ (Fcgamma-R+) P815 target cell line. Lysis of P815 target cells, triggered by an anti-CD3 or by anti-CD16 MoAb, could be inhibited by the addition of anti-p58 MoAb in three fresh or interleukin (IL)-2-cultured GL tested (GI, MA, and PU). Triggering of cytotoxicity against the HLA-DR+ Fcgamma-R+ Daudi cell line induced by appropriate superantigens could also be inhibited by anti-p58 MoAb in patients PU and GI with LDGL. These data indicate that activation through the CD16, CD3, and TCR molecules can be modulated by p58 receptors in these LDGLs. On the contrary, IL-2-expanded cells of patient BA were induced to lyse P815 target cells by anti-p58 MoAb. In addition, anti-p58 MoAB enhanced anti-CD16 MoAb triggered lysis and did not inhibit activation via CD3. These data indicate that, in this particular patient with LDGL, p58 displays a stimulatory effect on cell triggering, rather than the typical inhibitory effect previously observed in p58+ T-cell clones derived from healthy donors. The anti-p58 MoAb did not induce CA++ mobilization in p58+ LDGLs and in a p58+CD3+ normal T-cell clone equipped with inhibitory p58 molecules, while Ca++ mobilization could be observed in cultured GL from patient BA, which could be activated by anti-58 MoAb. These findings suggest that stimulatory and inhibitory p58 molecules are equipped with different signal transducing properties, thus contributing to a better knowledge of the normal counterpart.
Similar articles
-
T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.Eur J Immunol. 1994 Oct;24(10):2294-8. doi: 10.1002/eji.1830241005. Eur J Immunol. 1994. PMID: 7925558
-
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.J Exp Med. 1995 Sep 1;182(3):875-84. doi: 10.1084/jem.182.3.875. J Exp Med. 1995. PMID: 7650491 Free PMC article.
-
The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.Eur J Immunol. 1994 Oct;24(10):2527-34. doi: 10.1002/eji.1830241040. Eur J Immunol. 1994. PMID: 7523145
-
Surface molecules involved in CD3-negative NK cell function. A novel molecule which regulates the activation of a subset of human NK cells.Int J Cancer Suppl. 1989;4:48-52. doi: 10.1002/ijc.2910440713. Int J Cancer Suppl. 1989. PMID: 2478490 Review.
-
Natural killer receptors in patients with lymphoproliferative diseases of granular lymphocytes.Semin Hematol. 2003 Jul;40(3):201-12. doi: 10.1016/s0037-1963(03)00134-3. Semin Hematol. 2003. PMID: 12876669 Review.
Cited by
-
HLA-C revisited. Ten years of change.Immunol Res. 1997;16(2):203-14. doi: 10.1007/BF02786363. Immunol Res. 1997. PMID: 9212365 Review.
-
Effect of recombinant cytokines on the expression of natural killer cell receptors from patients with TB or/and HIV infection.PLoS One. 2012;7(6):e37448. doi: 10.1371/journal.pone.0037448. Epub 2012 Jun 8. PLoS One. 2012. PMID: 22715368 Free PMC article. Clinical Trial.
-
Chronic T cell receptor stimulation unmasks NK receptor signaling in peripheral T cell lymphomas via epigenetic reprogramming.J Clin Invest. 2021 Jul 1;131(13):e139675. doi: 10.1172/JCI139675. J Clin Invest. 2021. PMID: 34043588 Free PMC article.
-
Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor.Cancers (Basel). 2021 May 28;13(11):2673. doi: 10.3390/cancers13112673. Cancers (Basel). 2021. PMID: 34071607 Free PMC article.
-
How I treat LGL leukemia.Blood. 2011 Mar 10;117(10):2764-74. doi: 10.1182/blood-2010-07-296962. Epub 2010 Dec 29. Blood. 2011. PMID: 21190991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials